会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
    • 可用作PDE4同功酶抑制剂的嘧啶甲酰胺
    • US06740655B2
    • 2004-05-25
    • US10181417
    • 2002-07-24
    • Thomas Victor MageeAnthony MarfatRobert James Chambers
    • Thomas Victor MageeAnthony MarfatRobert James Chambers
    • A61K3138
    • C07D239/34A61K45/06C07D405/12C07D405/14C07D409/12C07D409/14C07D417/14
    • This invention is directed to compounds of the formula: wherein j is 0 or 1; k is 0 or 1; m is 0 or 1; n is 0 or 1; W is —O—; —S(═O)t—, where t is 0, 1, or 2; or —N(R3)—; where R3 is —H, —(C1-C3) alkyl, —OR12, phenyl, or benzyl; RC and RD have the same meaning as RA and RB, except that at least one of RC and RD must be —H; and the other variables are defined as set forth in the specification. The invention is also directed to pharmaceutical compositions comprising the above compounds and to methods of treating a subject suffering from a disease, disorder or condition mediated by the PDE4 isozyme, the method comprising administering a therapeutically effective amount of a compound as described above. The invention is particularly directed to methods of treating inflammatory, respiratory and allergic diseases and conditions, especially asthma; chronic obstructive pulmonary disease (COPD) including chronic bronchitis, emphysema, and bronchiectasis; chronic rhinitis; and chronic sinusitis.
    • 本发明涉及下式的化合物:其中j是0或1; k为0或1; m为0或1; n为0或1; W是-O-; -S(= O)t-,其中t为0,1或2; 或-N(R 3) - ; 其中R 3是-H, - (C 1 -C 3)烷基,-OR 12,苯基或苄基; R C和R D具有与R A和R B相同的含义,除了R C和R D中的至少一个必须为-H; 并且其他变量被定义为说明书中阐述的。 本发明还涉及包含上述化合物的药物组合物和治疗患有由PDE4同功酶介导的疾病,病症或病况的受试者的方法,所述方法包括施用治疗有效量的如上所述的化合物。 本发明特别涉及治疗炎性,呼吸和过敏性疾病和病症,特别是哮喘的方法; 慢性阻塞性肺疾病(COPD),包括慢性支气管炎,肺气肿和支气管扩张; 慢性鼻炎 和慢性鼻窦炎。
    • 2. 发明授权
    • Processes and intermediates for preparing 2-fluorothiophene derivatives
    • 制备2-氟噻吩衍生物的方法和中间体
    • US6096901A
    • 2000-08-01
    • US450976
    • 1999-11-30
    • Anthony MarfatRobert James Chambers
    • Anthony MarfatRobert James Chambers
    • C07D333/38
    • C07D333/38
    • A process for the preparation of the compound of the formula: ##STR1## wherein R.sup.1 is OH, which comprises the steps of a) treating the compound of the formula: ##STR2## with an inorganic fluoride, of the formula M.sup.2 F wherein M.sup.2 is an alkali metal cation, at an elevated temperature in the presence of a compound of the formula R.sup.4 P.sup.+ Z.sup.- and a compound of the formula R.sup.5 vic (COW).sub.2 wherein R.sup.4 and R.sup.5 are each selected from optionally substituted (C.sub.6 -C.sub.10) aryl and optionally substituted (C.sub.1 -C.sub.6) alkyl, and W is halo; to form the compound of the formula: ##STR3## and b) I) treating the compound of the formula IV with an aqueous solution of a base, of the formula MOH, wherein M is an alkali metal cation, andii) treating the product of step i) with a mineral acid. A compound of the formula: ##STR4## wherein R.sup.1 is selected from the group consisting of, halo, R.sup.7 O, R.sup.7 COO and N(R.sup.8).sub.2 wherein R.sup.7 is (C.sub.1 -C.sub.6)alkyl or (C.sub.6 -C.sub.10)aryl and each R.sup.8 is selected from hydrogen and R.sup.7 with the proviso that R.sup.7 is not methyl when R.sup.1 is R.sup.7 O.
    • 一种制备下式化合物的方法,其中R1是OH,其包括以下步骤:a)用式M2F的无机氟化物处理其中M2为碱金属阳离子的式 在式R4P + Z-的化合物和式的化合物R5vic(COW)2的存在下升高温度,其中R 4和R 5各自选自任选取代的(C 6 -C 10)芳基和任选取代的(C 1 -C 6) 烷基,W是卤素; 形成下式的化合物:和b)I)用式MOH的碱的水溶液处理式IV的化合物,其中M是碱金属阳离子,和ii)处理步骤i的产物 )与无机酸。 下式的化合物:其中R 1选自卤素,R 7 O,R 7 COO和N(R 8)2,其中R 7是(C 1 -C 6)烷基或(C 6 -C 10)芳基,并且每个R 8选自氢 和R 7,条件是当R 1是R 7 O时,R 7不是甲基。
    • 4. 发明授权
    • Processes and intermediates for preparing 2-fluorothiophene derivatives
    • 制备2-氟噻吩衍生物的方法和中间体
    • US6043379A
    • 2000-03-28
    • US355265
    • 1999-07-26
    • Anthony MarfatRobert James Chambers
    • Anthony MarfatRobert James Chambers
    • C07D333/38
    • C07D333/38
    • A process for the preparation of the compound of the formula ##STR1## wherein R.sup.1 is OH, which comprises the steps of a) treating the compound of the formula ##STR2## with an inorganic fluoride, of the formula M.sup.2 F wherein M.sup.2 is an alkali metal cation, at an elevated temperature in the presence of a compound of the formula R.sup.4 P.sup.+ Z.sup.- and a compound of the formula R.sup.5 vic (COW).sub.2 wherein R.sup.4 and R.sup.5 are each selected from optionally substituted (C.sub.6 -C.sub.10)aryl and optionally substituted (C.sub.1 -C.sub.6)alkyl, and W is halo; to form the compound of the formula; ##STR3## and b) i) treating the compound of the formula IV with an aqueous solution of a base, of the formula MOH, wherein M is an alkali metal cation, andii) treating the product of step i) with a mineral acid. A compound of the formula ##STR4## wherein R.sup.1 is selected from the group consisting of, halo, R.sup.7 O, R.sup.7 COO and N(R.sup.8).sub.2 wherein R.sup.7 is (C.sub.1 -C.sub.6)alkyl or (C.sub.6 -C.sub.10)aryl and each R.sup.8 is selected from hydrogen and R.sup.7 with the proviso that R.sup.7 is not methyl when R.sup.1 is R.sup.7 O.
    • PCT No.PCT / IB98 / 00304 Sec。 371日期:1999年7月26日 102(e)1999年7月26日PCT 1998年3月9日PCT PCT。 出版物WO98 / 45282 日期1998年10月15日制备下式化合物的方法其中R1是OH,其包括以下步骤:a)用式M2F的无机氟化物处理式的化合物,其中M2是碱金属阳离子 在式R4P + Z-的化合物和式R 5 vic(COW)2的化合物的存在下,在升高的温度下,其中R 4和R 5各自选自任选取代的(C 6 -C 10)芳基和任选取代的(C 1 -C 10) -C 6)烷基,W是卤素; 形成式的化合物; 和b)i)用式MOH的碱的水溶液处理式IV的化合物,其中M是碱金属阳离子,和ii)用无机酸处理步骤i)的产物。 下式的化合物其中R 1选自卤素,R 7 O,R 7 COO和N(R 8)2,其中R 7是(C 1 -C 6)烷基或(C 6 -C 10)芳基,并且每个R 8选自氢和 R7,条件是当R1为R7O时,R7不是甲基。